Keyphrases
Radiotherapy
86%
Programmed Death-ligand 1 (PD-L1)
81%
In Cancer
80%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
68%
Cancer Cells
66%
Programmed Death-ligand 1 Expression
55%
Indonesia
55%
Radiosensitization
45%
Tumor
43%
DNA Damage
41%
Radiosensitivity
40%
Tumor Microenvironment
31%
PD-L1 Expression
31%
X-ray Irradiation
29%
DNA Damage Signaling
29%
High Linear Energy Transfer
27%
DNA Double-strand Break Repair
27%
Clonogenic Assay
27%
Indonesian
27%
Glioblastoma multiforme
27%
Vitamin D
27%
Low-middle Income Countries
27%
CD8+ T Cells
24%
Ionizing Radiation
24%
X-ray
23%
Cancer Cell Lines
23%
Tumor Cells
23%
Colorectal Cancer
22%
Overall Survival
21%
Immune Response
21%
Carbon Ion Irradiation
17%
Tumor-infiltrating Immune Cells
17%
Radiotherapy Utilisation
17%
Utilization Rate
17%
Tumor Volume
17%
Ku80
16%
Genomic Data
16%
Cancer Genomics
16%
PD-L1 Downregulation
16%
3D Structured Illumination Microscopy
16%
Radiation Therapy
16%
5-year Survival
15%
Tumor Immunity
15%
Radiotherapy-induced
15%
Double-strand Break Repair
15%
Radiotherapy Services
15%
Repair Pathway
14%
Radioresistance
14%
Forkhead Box P3 (FOXP3)
14%
Cancer Development
13%
Medicine and Dentistry
Radiation Therapy
100%
Nasopharynx Cancer
68%
Neoplasm
58%
Programmed Death-Ligand 1
41%
Radiosensitivity
38%
Immunocompetent Cell
31%
Cancer Cell
30%
Malignant Neoplasm
29%
Tumor Microenvironment
28%
X-Ray Irradiation
27%
Cancer Cell Line
27%
Cervical Cancer
27%
Colorectal Carcinoma
22%
Tumor Cell
21%
Carcinogenesis
19%
Overall Survival
18%
Upregulation
17%
Cancer Radiotherapy
15%
Epstein Barr Virus
15%
Golgi Apparatus
13%
Cell Marker
13%
Prognostic Factor
13%
Quality of Life
13%
Cancer Tissue
13%
Radiosensitizer
13%
Annona muricata
13%
Systematic Review
13%
Clonogenic Assay
13%
Glioblastoma
13%
Calreticulin
13%
COVID-19
13%
Ionizing Radiation
13%
Oncoprotein
13%
Non-Homologous End Joining
13%
Elderly Patient
13%
Frailty
13%
Geriatrics
13%
Patient Referral
13%
Acute Toxicity
13%
External Beam Radiotherapy
13%
Vitamin D
13%
Virus
13%
Intracranial Tumor
13%
Precision Oncology
13%
Mutational Analysis
13%
Colon Carcinoma
12%
Rectum Cancer
12%
CD8 Antigen
9%
Biopsy Technique
9%
Cancer Therapy
8%
Immunology and Microbiology
Programmed Death 1 Ligand 1
55%
DNA Damage
48%
Radioresistance
42%
X Ray
41%
Cancer Cell
38%
Upregulation
30%
FOXP3
27%
Linear Energy Transfer
27%
Programmed Death-Ligand 1
27%
Immune Response
26%
Clonogenic Assay
24%
Cytotoxic T-Cell
24%
Cancer Cell Line
20%
Squamous Cell
18%
Tumor Cell
18%
CD4
18%
Normal Human
17%
Double-Strand DNA Break
15%
Illumination
15%
Colon
15%
Epstein Barr Virus
15%
Immunocompetent Cell
15%
P53
14%
Viral Load
13%
Tumor Volume
13%
Caspase
13%
Xenograft
13%
Preclinical Study
13%
Human Leukocyte Antigen
13%
Human Cell
13%
Cell Marker
13%
CD25
13%
Red Alga
13%
Cell Cycle Regulation
13%
Fibroblast
13%
Cancer Tissue
13%
Tumor Immunity
13%
Ring Finger
13%
Calreticulin
13%
Prostate
13%
Virus
13%
Excision Repair
13%
DNA End Joining Repair
13%
Regulatory T Cell
13%
Cell Infiltration
11%
CD8
11%
Nonsense Mediated mRNA Decay
11%
Ataxia Telangiectasia
9%
Cell Line
9%
T Cell
7%